Clinical Trials in Tennessee

Showing 8161-8180 of 15,329 trials

Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.

NCT01439152

BAY94-9343 was an antibody-drug conjugate (ADC) directed against the cancer antigen mesothelin on tumor cells.

Bayer148 participantsStarted Sep 2011

New Haven, Connecticut, United States • Chicago, Illinois, United States • Bethesda, Maryland, United States +5 more locations

COMPLETEDPhase 229 miles

Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer

NCT00361842

The purpose of this study is to determine whether CPX-1 is effective in patients with advanced colorectal cancer who have already received chemotherapy that included the drug oxaliplatin or irinotecan. All patients will receive CPX-1 at a dose of 210 units/m2 over 90 minutes every two weeks.

Colorectal Neoplasms

Jazz Pharmaceuticals65 participantsStarted Jul 2006

Greenbrae, California, United States • Washington D.C., District of Columbia, United States • Coral Springs, Florida, United States +10 more locations

Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.

Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer

Find Trials by Condition in Tennessee

A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

Rectal Safety and Acceptability Study of Tenofovir 1% Gel

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery

Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)

A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia

NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b)

ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease

Viable Allograft Supplemented Disc Regeneration in the Treatment of Patients With Low Back Pain

Dysport in Hallux Abducto Valgus (HAV) Phase IIa

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients

A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia

A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD

Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy

Long Term Study of Canakinumab (ACZ885) in Patients With Gout